Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jul;85(1):70-3.
doi: 10.4269/ajtmh.2011.10-0680.

Lesion size correlates with Leishmania antigen-stimulated TNF-levels in human cutaneous leishmaniasis

Affiliations

Lesion size correlates with Leishmania antigen-stimulated TNF-levels in human cutaneous leishmaniasis

Fabiano Oliveira et al. Am J Trop Med Hyg. 2011 Jul.

Abstract

Cutaneous leishmaniasis (CL) is a worldwide disease endemic in several regions of the globe. The hallmark of CL is skin ulcers likely driven by efforts of the immune system to control Leishmania growth. Cytokines, such as tumor necrosis factor (TNF) and interferon-gamma can control disease progression in animal models. Nevertheless, the impact of these cytokines in CL ulcer outcome is not well established in humans. In this study, 96 CL patients from an endemic area of Leishmania braziliensis were enrolled for a follow-up study that consisted of clinical and immunological evaluations in a 2-year period. Statistical analysis revealed that healing time (P = 0.029), age (P = 0.002), and TNF levels (P = 0.0002) positively correlate with ulcer size at the time of the first clinical evaluation. Our findings suggest that ulcer size correlates with healing time and TNF levels support the use of TNF inhibitors combined with standard therapy to improve healing in CL patients with severe lesions.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Positive correlation between lesion size and healing time, age, or tumor necrosis factor (TNF) levels on cutaneous leishmaniasis (CL) patients. (A) Correlation between healing time (days) and lesion size (cm) (N = 70). (B) Correlation between patient age (years) and lesion size (cm) (N = 70). (C) Correlation between TNF levels in the supernatant measured by enzyme-linked immunosorbent assay (ELISA) (pg/mL) and lesion size (cm) (N = 52). The solid line represents the linear regression and the dotted line the 95% predicted coefficient interval. The Spearman correlation coefficient is designated in each figure by “rs.”
Figure 2.
Figure 2.
Positive correlation between cytokine levels on cutaneous leishmaniasis (CL) patients. (A) Correlation between tumor necrosis factor (TNF) and interferon-gamma (IFN- γ) levels (pg/mL) (N = 52). (B) Correlation between TNF and interleukin-10 (IL-10) levels (pg/mL) (N = 52). (C) Correlation between IFN- γ and IL-10 levels (pg/mL) (N = 52). The solid line represents the linear regression and the dotted line the 95% predicted coefficient interval. The Spearman correlation coefficient is designated in each figure by “rs.”
Figure 3.
Figure 3.
Comparison between lesion size and number of courses of SbV on cutaneous leishmaniasis patients. Data represent mean ± standard deviation of the measurements of lesion size in the group of patients that received either a single or several (two or three) courses of SbV during the study. The Mann-Whitney test was performed. (*) denotes statistical significance with P < 0.05.

Similar articles

Cited by

References

    1. Oliveira JG, Novais FO, de Oliveira CI, da Cruz Junior AC, Campos LF, da Rocha AV, Boaventura V, Noronha A, Costa JM, Barral A. Polymerase chain reaction (PCR) is highly sensitive for diagnosis of mucosal leishmaniasis. Acta Trop. 2005;94:55–59. - PubMed
    1. Rosa AC, Cuba CC, Vexenat A, Barreto AC, Marsden PD. Predominance of Leishmania braziliensis braziliensis in the regions of Tres Bracos and Corte de Pedra, Bahia, Brazil. Trans R Soc Trop Med Hyg. 1988;82:409–410. - PubMed
    1. Barral A, Guerreiro J, Bomfim G, Correia D, Barral-Netto M, Carvalho EM. Lymphadenopathy as the first sign of human cutaneous infection by Leishmania braziliensis. Am J Trop Med Hyg. 1995;53:256–259. - PubMed
    1. Gaafar A, Veress B, Permin H, Kharazmi A, Theander TG, el Hassan AM. Characterization of the local and systemic immune responses in patients with cutaneous leishmaniasis due to Leishmania major. Clin Immunol. 1999;91:314–320. - PubMed
    1. Pompeu MM, Brodskyn C, Teixeira MJ, Clarencio J, Van Weyenberg J, Coelho IC, Cardoso SA, Barral A, Barral-Netto M. Differences in gamma interferon production in vitro predict the pace of the in vivo response to Leishmania amazonensis in healthy volunteers. Infect Immun. 2001;69:7453–7460. - PMC - PubMed

Publication types

Substances

LinkOut - more resources